Document is current
Any future updates will be listed below
-
Authors
Chitpin, Jeremy https://orcid.org/0000-0002-3484-459X
Wammes, Michael
Ross, James
Pillai, Aiswarya
Demy, Jazzmin
Carter, Chloe
Tremblay, Paul
Vingilis, Evelyn
Osuch, Elizabeth https://orcid.org/0000-0001-5946-1862
- License Information
-
More Information
Article History
Received: 24 April 2023
Accepted: 28 May 2024
First Online: 21 June 2024
Competing interests
: The authors declare no competing interests.
: All documents and procedures were approved for use by the Health Sciences Research Ethics Board at Western University in full accordance with the Declaration of Helsinki, with REB approval #115748. Ethical approval was sought by E.A.O and M.W. on behalf of the study team.
: Willing participants signed electronic informed consent at the time of invitation prior to data collection. Participants received an email invitation to participate in a longitudinal study examining the effects of COVID-19 on FEMAP patients as early as April 10th, 2020, although data used in this study was collected during the “third wave,” from April 16th–21st, 2021. A Letter of Information was provided via email to participants prior to enrollment of the study. Consent was obtained using the REDCap electronic platform. Participants were able to meet with a study team member (M.W.) if they had concerns or required clarification regarding the study.
